Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 vaccines in Hong Kong.

Chris Ka Pun MokCarolyn A CohenSamuel M S ChengChunke ChenKin On On KwokKaren YiuTat-On ChanMaireid BullKwun Cheung LingZixi DaiSusanna S NgGrace Chung-Yan LuiChao WuGaya K AmarasingheDaisy W LeungSamuel Yeung Shan WongSophie A ValkenburgMalik PeirisDavid Shu Cheong Hui

Published in: Respirology (Carlton, Vic.) (2021)

Vaccination with BNT162b2 induces stronger humoral responses than CoronaVac. CoronaVac induces higher CD4+ and CD8+ T-cell responses to the structural protein than BNT162b2.

Keyphrases

coronavirus disease
sars cov
immune response
protein protein
small molecule
respiratory syndrome coronavirus